OKLO Nearly Halved in 2026: 240% Returns to Materialize in 12 Months Says One Wall Street Pro
Oklo has shed nearly half its value this year while one Wall Street analyst sees a path to more than triple the current price, and the gap between those two realities comes down to a single high-stakes question about timing.
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
Oklo (NYSE:OKLO | OKLO Price Prediction) is priced at $38.57. The average analyst price target sits at $75.78, which implies about 96% upside.
Oklo is building the Aurora powerhouse, a sodium-cooled fast reactor designed to sell electricity directly to customers under long-term power purchase agreements. A 12 GW master power agreement with Switch placed Oklo as a key play on AI power demand.
The gap matters because Oklo reported trailing revenue of just $1.21 million. Every target depends on plants still years from running, meaning either the market or analysts have the timeline badly wrong.
A Nuclear Darling Lost Nearly Half Its Value as the Market Climbed
Heavy share issuance is the biggest reason Oklo is down 46.25% this year. The company raised $1.9 billion through at-the-market programs in 2026, then started a fresh at-the-market equity program to replace the old one. Over the past year the stock has fallen 72.16%, and its 52-week range runs from $193.84 down to $34.38. That is a violent drawdown.
Spending sped up the decline. In Q2, management raised 2026 cash burn guidance to $120 million to $150 million from $80 to $100 million and lifted capital spending to $400 to $500 million. Aurora INL now targets a 2028 startup. The average 2026 EPS estimate fell to -0.9392 from -0.6955 90 days earlier.
Tigress Sees $130 as Oklo Hits Its Milestones
Tigress Financial’s Ivan Feinseth started coverage with a Buy rating and a $130.00 target, implying roughly 237% upside. His thesis: the own-and-operate model lets Oklo sell power at premium baseload rates; Aurora’s design with fuel recycling could lower fuel costs and unlock radioisotope revenue; and hyperscale data centers provide long-term demand.
Oklo has delivered on goals. Groves reached first criticality “a little over 11 months from groundbreaking,” and the Department of Energy approved Aurora INL’s preliminary safety analysis. Management expects first isotope revenue “in the first part of next year.” A HALEU letter of intent covers fuel for up to five powerhouses with deliveries starting in 2029. The company held $3 billion in cash and securities at quarter-end.
Of the 25 analysts covering Oklo, ratings break down as follows:
- Strong Buy: 6
- Buy: 9
- Hold: 9
- Strong Sell: 1
Earnings revisions point down. Over 30 days there were zero up revisions and two down ones. The average 2027 revenue estimate is $8,897,980.
Every SMR Name Sold Off, and Nano Nuclear Shows the Largest Gap
The whole group fell together, so Oklo’s slide is partly a sector move. NuScale Power (NYSE:SMR) is down 43.4% this year and 80.88% over 12 months. At $8.03 against a $11.97 target, it offers about 49% upside. Hold ratings lead its 18 analysts, with 10 Holds. Wall Street sees less upside there than at Oklo.
Nano Nuclear Energy (NASDAQ:NNE) is down 31.32% this year. At $16.49 against a $37.57 target, it implies about 128% upside. Six of its 8 analysts give it a Buy or Strong Buy recommendation, though coverage is thin and beta is 5.48.
Nano Nuclear has the largest analyst-implied upside in the group. Oklo sits in the middle with deeper coverage and a bigger cash buffer. The whole restart trade, utilities and fuel included, is the subject of a free report we put together on five nuclear names to own before the renaissance goes mainstream, here.
Oklo Trails the S&P 500 by a Wide Margin
At $38.57, Oklo would have to roughly double to reach the $75.78 consensus, about 96% upside across 25 analysts. The stock is down 46.25% this year, while the S&P 500 is up 14.26%.
Early signs of stabilization emerged. Shares rose 7.23% in the latest session and 3.93% over the past week, though the price remains below the 50-day moving average of $40.61 and the 200-day of $59.46.
Groves Proved Oklo Can Build, but Funding Still Decides the Outcome
Oklo looks compelling if Aurora INL starts on schedule in 2028, isotope revenue arrives next year, and customer capital funds more of the expansion. It looks like a value trap if costs climb, fuel timelines slip, and more share sales reduce holders before revenue flows.
Groves proved Oklo can execute, and $3 billion in cash buys time. The $130.00 target assumes near-flawless execution. A realistic test is whether Oklo closes the gap to the consensus target. Keep an eye on the next Aurora INL cost update.
Contact [email protected] for any questions or corrections.
Alex Sirois is a financial writer with experience spanning both retail and institutional investing. He has written for InvestorPlace and held roles at BNY Mellon and Bernstein, giving him a perspective that bridges Main Street portfolios and Wall Street analysis.
Alex holds an MBA from George Washington University and has built his career across multiple industries, including e-commerce, education, and translation — a breadth of experience that informs how he breaks down complex financial topics for everyday investors. His writing is conversational, actionable, and grounded in long-term, buy-and-hold investing principles.
At 247 Wall St., Alex focuses on delivering analysis that is both accessible and useful, with a clear emphasis on helping readers make more informed decisions with their money.
